Image (1b0db25b 4dd9 49fc B2b0 B18157d73bca 815 1)
Lurasidone Hydrochloride Tablet
Product Images NDC 70518-4427
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 70518-4427). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (98489a2d A33e 49d6 A23f 45932da3f7b0 793 1)
Remedy_label (Remedy Label)
Description: Lurasidone HCI 40mg tablets, with NDC number 70518442700, packaged in a quantity of 30 white, round tablets. This prescription medication is manufactured by Lupin Ltd in Goa, India. The usual dosage instructions can be found in the insert provided. Remember to keep this medication out of reach of children and store it at a temperature between 20-25°C (68-77°F), with excursions permitted to 15-30°C (59-86°F) as per USP guidelines. The product has been repackaged by RemedyRepack Inc. located in Indiana, PA.*
Image-01 (F34d847a 0e47 4cbf 9d96 B90e1fef1595 01)
Image-02 (F34d847a 0e47 4cbf 9d96 B90e1fef1595 02)
This text is about interacting drugs and their effects on certain enzymes. It mentions the drugs Ketoconazole, Diltiazem, Rifampin, and Lithium with their respective dosages. The text also refers to the interaction of these drugs with Strong CYPIAL Inhibitors and Inducers. Additionally, it briefly mentions PK parameters and Fold Change with 90% confidence interval in relation to Lurasidone alone.*
Image-03 (F34d847a 0e47 4cbf 9d96 B90e1fef1595 03)
Image-04 (F34d847a 0e47 4cbf 9d96 B90e1fef1595 04)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
